UNIVERSITY OF WISCONSIN - MADISON
← Return to course list
Developed & Conducted by the Division of Pharmacy Professional Development, School of Pharmacy, University of Wisconsin-Madison.
The September Land O’Lakes Conference on Drug Metabolism and Applied Pharmacokinetics is recognized worldwide as one of the premier teaching conferences for pharmaceutical scientists. This conference brings leaders from multiple disciplines in the Drug Metabolism and Pharmacokinetics arena together to share new advances in drug delivery, action and metabolism. Relevant regulatory updates are provided every year to ensure that the attendees are aware of the latest changes in drug development regulations.
601 University Avenue
University of Wisconsin-Madison Campus
$850 Academic-Government rate
$1375 after Sept 3
$175 Optional Short Course
The purpose of this three-day conference is to provide an educational forum to discuss the current issues in selecting potential new therapeutic entities for drug development and current issues in drug metabolism, drug transport, pharmacokinetics, and pharmacodynamics.
The objectives for this conference include:
Call for Posters 2018DMPK
The Planning Committee for the 21st Annual Land O’Lakes Conference on Drug Metabolism and Pharmacokinetics and Applied Drug Development, invites interested parties to submit research poster abstracts for the 2018 Conference Poster Session on Wednesday, September 19, at the Fluno Center, Madison, Wisconsin.
All abstracts must be submitted via email to the University of Wisconsin by Monday, July 23, 2018. Proposals will be reviewed and evaluated by a review panel of Planning Committee members. Acknowledgement of receipt will be sent by e-mail, as well as notification of the acceptance or rejection of abstracts to primary presenters by August 13. Please do not call the University of Wisconsin to find out the status of your abstract(s).
To submit a poster for consideration, at least one author must be registered for the conference. If the poster is not accepted, authors have the right to cancel their registration by the registration deadline of September 3 and will receive a full refund. Any author present at the Conference must be registered for the entire Conference.
Accepted abstracts will be placed on the University of Wisconsin Web site by August 20, 2018.
Drug metabolism and delivery scientists and managers from virtual to big pharma, CROs and researchers in academia will all benefit from attending this conference. The planning committee sought to include perspectives from the regulatory, industrial and academic disciplines to ensure a broad diversity of thought.
Optional Pre-Conference Short Course:
Speaker: Daniel Bow, Senior Principal Scientist, AbbVie, Inc.
Opening Remarks and David Hartman Memorial Dinner
Plenary Session 1: Mechanistic PK/PD
Good Practices in Model Informed Drug Discovery and Development (MID3)
Day-to-Day Applications of PK/PD: Optimizing Utility and Avoiding Pitfalls
PK/PD Modelling of Indirect Systems and Covalent Inactivators
Biomarker Approaches for Modelling Drug Action
Plenary Session 2: New Regulatory Considerations (New FDA/EMA Guidances)
Moderator: Gord Loewen, PhD, Neurocrine Biosciences, Inc., Co-Chair
In vitro DD1 Guidance: The in vitro DD1 guidance covering inhibition and induction and reaction phenotyping
Speaker: Mike Sinz, PhD, Director, DMPK, Bristol-Myers Squibb
Clinical DD1 Guidance
EMA guideline on first-in-human and early clinical trails
Speaker: Dr. John Lambert MB, BS, PhD, FRACP, FFPM, Chief Medical Officer Early Phase, Corporate Vice, President, Head Global Early Phase Medical Sciences, PAREXEL International
Moderators: Mike Sinz, John Lambert
Plenary Session 3: Special Topics in Metabolism
Moderator: Larry Jolivette, PhD, Director of DMPK, GlaxoSmithKline
Assessing Metabolite Profile and DD1 Profile for Low Clearance compounds
Non P450 Metabolism
What is the Microbiome and its effects on Physiology/Disease State
Poster Reception/Graduate Research Presentations
Plenary Session 5: Optimizing Translational Drug Development (Early Drug Development Preclinical-Clincial)
Translational Drug Development: What Preclincial Data are Required and How is it Best Integrated into Early Clinical Drug Developement
Speaker: Griff Humphreys, PhD, Executive Director, Bristol-Myers Squibb,
Dosimetry for Human ADME Studies
Speaker: Eric Solon, PhD, Senior Director, Pharmacology and ADME, Madrigal Pharmaceuticals
Adaptive Trial Models
Panel Discussion and Conference Wrap Up
Griff Humphreys, PhD, Executive Director, Bristol-Myers Squibb, Princeton, NJ
Larry Jolivette, PhD, Director of DMPK, GlaxoSmithKline
Dr John Lambert MB BS, PhD, FRACP, FFPM, Chief Medical Officer Early Phase, Corporate Vice President, Head Global Early Phase Medical Sciences , PAREXEL International, Middlesex, UK
Mike Sinz, PhD, Director DMPK, at Bristol-Myers Squibb, Wallingford, CT
Eric Solon, PhD, Senior Director, Pharmacology and ADME, Madrigal Pharmaceuticals, West Conshohocken, PA
Daniel A Bow, PhD, Abbott, Abbott Park, IL
Matthew Cerny, PhD, Pfizer, Groton, CT
Stephanie Pasas-Farmer, PhD, Bio Data Solutions, Inc, Eagleview, PA
Randall H. Guthrie, Co-Chair, Pyxant Labs, Lodi, WI
Robert J. Guttendorf, RPh, PhD, CSO and Senior Consultant, Clinical Pharmacology and DMPK, Aclairo Pharmaceutical Development Group, Vienna, VA, Co-Chair
Kirk Henne, PhD, Denali Therapeutics, South San Francisco, CA
Larry J. Jolivette, PhD, GlaxoSmithKline, Upper Merion, PA
Stefan Linehan, Imabiotech Corp, Cambridge, MA
Gordon Loewen, PhD, Neurocrine Biosciences, Inc., Co-Chair
Celeste R. MacElrevey, PhD, Nuventra Pharma Sciences, Inc., Exton, PA
Donald L McKenzie, PhD, Covance Laboratories, Madison, WI
Dan Norris, PhD, Ionis Pharmaceuticals, Carlsbad, CA
Michael Sinz, PhD, Bristol Myers Squibb, Wallingford, CT
Jennifer Thomas, PhD, Associate Director, ADME/DMPK, Charles River, Ashland, OH
Hotel accommodations are the responsibility of the registrant.
The Graduate Madison
(1.5 blocks away)
601 Langdon St
Madison, WI 53703
Event Title: UW School of Pharmacy - June Land O Lakes Conference
601 University Ave
Madison, WI 53715
(5 blocks away)
440 West Johnson St
Madison, WI 53703
Group Code: Land O' Lakes Conference September
Eric Buxton, PhD
Division of Pharmacy Professional Development 777 Highland Avenue Madison, WI 53705 (608) 262-2431 FAX (608) 265-2259 firstname.lastname@example.org